Sageworth Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.61M | Sell |
18,313
-4,697
| -20% | -$1.01M | 0.18% | 30 |
|
|
2026
Q1 | $5M | Buy |
23,010
+300
| +1% | +$66.5K | 0.22% | 28 |
|
|
2025
Q4 | $5.19M | Sell |
22,710
-6,451
| -22% | -$1.47M | 0.22% | 26 |
|
|
2025
Q3 | $6.75M | Buy |
29,161
+7,172
| +33% | +$1.46M | 0.31% | 26 |
|
|
2025
Q2 | $4.08M | Sell |
21,989
-20
| -0.1% | -$3.72K | 0.23% | 27 |
|
|
2025
Q1 | $4.61M | Buy |
22,009
+59
| +0.3% | +$11.5K | 0.29% | 24 |
|
|
2024
Q4 | $3.9M | Sell |
21,950
-743
| -3% | -$137K | 0.24% | 25 |
|
|
2024
Q3 | $4.48M | Sell |
22,693
-12,160
| -35% | -$2.27M | 0.27% | 25 |
|
|
2024
Q2 | $5.98M | Sell |
34,853
-2,411
| -6% | -$399K | 0.38% | 20 |
|
|
2024
Q1 | $6.79M | Sell |
37,264
-550
| -1% | -$94.8K | 0.44% | 21 |
|
|
2023
Q4 | $5.86M | Sell |
37,814
-1
| -0% | -$146 | 0.4% | 21 |
|
|
2023
Q3 | $5.64M | Hold |
37,815
| – | – | 0.41% | 24 |
|
|
2023
Q2 | $5.09M | Sell |
37,815
-73
| -0.2% | -$10.7K | 0.36% | 19 |
|
|
2023
Q1 | $6.04M | Buy |
37,888
+35
| +0.1% | +$5.35K | 0.45% | 20 |
|
|
2022
Q4 | $6.12M | Buy |
37,853
+38
| +0.1% | +$5.83K | 0.49% | 18 |
|
|
2022
Q3 | $5.08M | Sell |
37,815
-1,475
| -4% | -$212K | 0.45% | 17 |
|
|
2022
Q2 | $6.02M | Buy |
39,290
+1,913
| +5% | +$292K | 0.52% | 15 |
|
|
2022
Q1 | $6.06M | Sell |
37,377
-2,332
| -6% | -$339K | 0.47% | 15 |
|
|
2021
Q4 | $5.38M | Hold |
39,709
| – | – | 0.42% | 19 |
|
|
2021
Q3 | $4.28M | Sell |
39,709
-300
| -0.7% | -$34.3K | 0.34% | 21 |
|
|
2021
Q2 | $4.51M | Sell |
40,009
-461
| -1% | -$51.9K | 0.35% | 17 |
|
|
2021
Q1 | $4.38M | Sell |
40,470
-292
| -0.7% | -$31.2K | 0.36% | 19 |
|
|
2020
Q4 | $4.37M | Buy |
40,762
+292
| +0.7% | +$28.1K | 0.4% | 22 |
|
|
2020
Q3 | $3.54M | Sell |
40,470
-67,009
| -62% | -$6.31M | 0.38% | 23 |
|
|
2020
Q2 | $10.6M | Sell |
107,479
-99
| -0.1% | -$8.72K | 1.18% | 10 |
|
|
2020
Q1 | $8.2M | Sell |
107,578
-2,945
| -3% | -$251K | 1.01% | 14 |
|
|
2019
Q4 | $9.79M | Sell |
110,523
-1,785
| -2% | -$148K | 1.06% | 9 |
|
|
2019
Q3 | $8.5M | Sell |
112,308
-752
| -0.7% | -$51.6K | 0.99% | 11 |
|
|
2019
Q2 | $8.22M | Buy |
113,060
+2,945
| +3% | +$231K | 0.97% | 12 |
|
|
2019
Q1 | $8.87M | Buy |
110,115
+461
| +0.4% | +$37.7K | 1.1% | 12 |
|
|
2018
Q4 | $10.1M | Sell |
109,654
-20
| -0% | -$1.76K | 1.34% | 11 |
|
|
2018
Q3 | $10.4M | Buy |
109,674
+547
| +0.5% | +$51.9K | 1.4% | 7 |
|
|
2018
Q2 | $10.1M | Sell |
109,127
-277
| -0.3% | -$27.1K | 1.45% | 8 |
|
|
2018
Q1 | $10.4M | Sell |
109,404
-2,006
| -2% | -$220K | 1.54% | 8 |
|
|
2017
Q4 | $10.8M | Sell |
111,410
-527
| -0.5% | -$49.7K | 1.87% | 7 |
|
|
2017
Q3 | $9.95M | Buy |
111,937
+11,352
| +11% | +$864K | 1.87% | 7 |
|
|
2017
Q2 | $7.29M | Hold |
100,585
| – | – | 1.45% | 9 |
|
|
2017
Q1 | $6.55M | Hold |
100,585
| – | – | 1.34% | 10 |
|
|
2016
Q4 | $6.3M | Hold |
100,585
| – | – | 1.37% | 10 |
|
|
2016
Q3 | $6.34M | Hold |
100,585
| – | – | 1.45% | 10 |
|
|
2016
Q2 | $6.23M | Sell |
100,585
-433
| -0.4% | -$26.4K | 1.51% | 10 |
|
|
2016
Q1 | $5.77M | Buy |
101,018
+433
| +0.4% | +$24.1K | 1.39% | 11 |
|
|
2015
Q4 | $5.96M | Hold |
100,585
| – | – | 1.44% | 11 |
|
|
2015
Q3 | $5.47M | Hold |
100,585
| – | – | 1.57% | 10 |
|
|
2015
Q2 | $6.76M | Hold |
100,585
| – | – | 2.18% | 7 |
|
|
2015
Q1 | $5.89M | Sell |
100,585
-448
| -0.4% | -$27.1K | 1.93% | 8 |
|
|
2014
Q4 | $6.61M | Buy |
101,033
+448
| +0.4% | +$28.2K | 2.01% | 7 |
|
|
2014
Q3 | $5.81M | Hold |
100,585
| – | – | 2.13% | 8 |
|
|
2014
Q2 | $5.68M | Hold |
100,585
| – | – | 2.05% | 8 |
|
|
2014
Q1 | $5.17M | Hold |
100,585
| – | – | 1.96% | 8 |
|
|
2013
Q4 | $5.31M | Buy |
100,585
+4,265
| +4% | +$210K | 1.93% | 10 |
|
|
2013
Q3 | $4.31M | Sell |
96,320
-1,000
| -1% | -$44.3K | 1.75% | 9 |
|
|
2013
Q2 | $4.43M | Buy |
+97,320
| New | +$4.26M | 1.89% | 9 |
|
Other funds holding ABBV
Sageworth Trust's ABBV Position: Q2 2026 in Review
Sageworth Trust reduced its AbbVie (ABBV) stake by 20% in Q2 2026, selling an estimated $1.01M and leaving 18,313 shares worth $4.61M. The position accounts for 0.18% of the portfolio, ranked #30.
Sageworth Trust first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.8M in Q4 2017. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sageworth Trust held 18,313 shares of AbbVie worth $4.61M as of Q2 2026.
- Sageworth Trust sold 4,697 AbbVie shares in Q2 2026, an estimated $1.01M.
- AbbVie made up 0.18% of Sageworth Trust's portfolio in Q2 2026, its #30 holding.
- Sageworth Trust first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Sageworth Trust's AbbVie position peaked at $10.8M in Q4 2017.
- 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sageworth Trust's 13F filing for Q2 2026, filed 28 Jul 2026.